Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Evercore ISI Group Downgrades M.D.C. Holdings to In-Line, Raises Price Target to $63

Author: Benzinga Newsdesk | January 31, 2024 11:15am
Evercore ISI Group analyst Stephen Kim downgrades M.D.C. Holdings (NYSE:MDC) from Outperform to In-Line and raises the price target from $57 to $63.

Posted In: MDC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist